← Back to Analyst Consensus 
LRN Buy
Stride, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Oct 5, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Apr 16, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Jan 28, 2026 | Canaccord Genuity | maintain | Buy → Buy | $125 | 48% |
| Jan 28, 2026 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Jan 21, 2026 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Dec 17, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $95 | 54% |
| Nov 7, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $82 | 53% |
| Oct 29, 2025 | Canaccord Genuity | maintain | Buy → Buy | $125 | 48% |
| Oct 29, 2025 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Oct 29, 2025 | BMO Capital | downgrade | Outperform → Market Perform | $108 | 53% |
| Oct 24, 2025 | Canaccord Genuity | maintain | Buy → Buy | $175 | 48% |
| Sep 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $185 | 56% |
| Aug 29, 2025 | Barrington Research | maintain | Outperform → Outperform | $185 | 56% |
| Aug 6, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $159 | 54% |
| Jul 24, 2025 | Barrington Research | maintain | Outperform → Outperform | $170 | 56% |
| Apr 30, 2025 | Barrington Research | maintain | Outperform → Outperform | $170 | 56% |
| Apr 28, 2025 | Canaccord Genuity | maintain | Buy → Buy | $155 | 48% |
| Apr 17, 2025 | Barrington Research | maintain | Outperform → Outperform | $150 | 56% |
| Apr 1, 2025 | BMO Capital | maintain | Outperform → Outperform | $139 | 53% |
| Mar 14, 2025 | Barrington Research | maintain | Outperform → Outperform | $140 | 56% |
| Mar 11, 2025 | Canaccord Genuity | maintain | Buy → Buy | $145 | 48% |
| Jan 30, 2025 | BMO Capital | maintain | Outperform → Outperform | $134 | 53% |
| Jan 29, 2025 | Barrington Research | maintain | Outperform → Outperform | $140 | 56% |
| Jan 29, 2025 | Canaccord Genuity | maintain | Buy → Buy | $135 | 48% |
| Jan 27, 2025 | Canaccord Genuity | maintain | Buy → Buy | $130 | 48% |
| Jan 17, 2025 | Barrington Research | maintain | Outperform → Outperform | $130 | 56% |
| Dec 12, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $109 | 54% |
| Oct 29, 2024 | Citigroup | maintain | Neutral → Neutral | $94 | 54% |
| Oct 24, 2024 | BMO Capital | maintain | Outperform → Outperform | $88 | 53% |
| Aug 20, 2024 | Citigroup | downgrade | Buy → Neutral | $90 | 54% |
| Aug 8, 2024 | Barrington Research | maintain | Outperform → Outperform | $90 | 56% |
| Aug 8, 2024 | BMO Capital | maintain | Outperform → Outperform | $82 | 53% |
| Aug 8, 2024 | Canaccord Genuity | initiate | — → Buy | $94 | 48% |
| Jul 31, 2024 | Barrington Research | maintain | Outperform → Outperform | $85 | 56% |
| Apr 25, 2024 | BMO Capital | maintain | Outperform → Outperform | $73 | 53% |
| Apr 24, 2024 | Barrington Research | maintain | Outperform → Outperform | $75 | 56% |
| Apr 17, 2024 | Barrington Research | maintain | Outperform → Outperform | $75 | 56% |
| Jan 29, 2024 | Citigroup | maintain | Buy → Buy | $75 | 54% |
| Jan 25, 2024 | BMO Capital | maintain | Outperform → Outperform | $72 | 53% |
| Jan 24, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $65 | 54% |
| Jan 24, 2024 | Barrington Research | maintain | Outperform → Outperform | $75 | 56% |
| Dec 4, 2023 | Barrington Research | reiterate | Outperform → Outperform | $70 | 56% |
| Nov 16, 2023 | BMO Capital | maintain | Outperform → Outperform | $67 | 53% |
| Nov 16, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $60 | 54% |
| Oct 26, 2023 | BMO Capital | maintain | Outperform → Outperform | $57 | 53% |
| Oct 25, 2023 | Barrington Research | maintain | Outperform → Outperform | $60 | 56% |
| Oct 25, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $57 | 54% |
| Aug 16, 2023 | Barrington Research | reiterate | Outperform → Outperform | $50 | 56% |
| Aug 16, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $52 | 54% |
Price Target Trend
Jul 10, 2026 Latest: $102.5 Oct 25, 2026
EPS Estimates
0q $2.44
Lo: $2.42 Hi: $2.46
3 analysts +1q $2.76
Lo: $2.75 Hi: $2.77
3 analysts ▲1
0y $9.00
Lo: $8.94 Hi: $9.09
3 analysts ▲1
+1y $9.61
Lo: $9.53 Hi: $9.73
3 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days